These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 10445384)

  • 1. Naringenin and interindividual variability in interaction of coumarin with grapefruit juice.
    Bourian M; Runkel M; Krisp A; Tegtmeier M; Freudenstein J; Legrum W
    Exp Toxicol Pathol; 1999 Jul; 51(4-5):289-93. PubMed ID: 10445384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic and analytical interactions of grapefruit juice and 1,2-benzopyrone (coumarin) in man.
    Runkel M; Tegtmeier M; Legrum W
    Eur J Clin Pharmacol; 1996; 50(3):225-30. PubMed ID: 8737764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The fate of naringin in humans: a key to grapefruit juice-drug interactions?
    Fuhr U; Kummert AL
    Clin Pharmacol Ther; 1995 Oct; 58(4):365-73. PubMed ID: 7586927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma kinetics and urinary excretion of the flavanones naringenin and hesperetin in humans after ingestion of orange juice and grapefruit juice.
    Erlund I; Meririnne E; Alfthan G; Aro A
    J Nutr; 2001 Feb; 131(2):235-41. PubMed ID: 11160539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The character of inhibition of the metabolism of 1,2-benzopyrone (coumarin) by grapefruit juice in human.
    Runkel M; Bourian M; Tegtmeier M; Legrum W
    Eur J Clin Pharmacol; 1997; 53(3-4):265-9. PubMed ID: 9476043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A method for measuring naringenin in biological fluids and its disposition from grapefruit juice by man.
    Lee YS; Reidenberg MM
    Pharmacology; 1998 Jun; 56(6):314-7. PubMed ID: 9654218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Content of CYP3A4 inhibitors, naringin, naringenin and bergapten in grapefruit and grapefruit juice products.
    Ho PC; Saville DJ; Coville PF; Wanwimolruk S
    Pharm Acta Helv; 2000 Apr; 74(4):379-85. PubMed ID: 10812937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lacking effect of grapefruit juice on theophylline pharmacokinetics.
    Fuhr U; Maier A; Keller A; Steinijans VW; Sauter R; Staib AH
    Int J Clin Pharmacol Ther; 1995 Jun; 33(6):311-4. PubMed ID: 7582380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of grapefruit juice on cytochrome P450 2A6 and nicotine renal clearance.
    Hukkanen J; Jacob P; Benowitz NL
    Clin Pharmacol Ther; 2006 Nov; 80(5):522-30. PubMed ID: 17112808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-dose methoxsalen effects on human cytochrome P-450 2A6 activity.
    Kharasch ED; Hankins DC; Taraday JK
    Drug Metab Dispos; 2000 Jan; 28(1):28-33. PubMed ID: 10611136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naringin and naringenin are not the primary CYP3A inhibitors in grapefruit juice.
    Edwards DJ; Bernier SM
    Life Sci; 1996; 59(13):1025-30. PubMed ID: 8809221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Grapefruit juice inhibits 7-hydroxylation of coumarin in healthy volunteers.
    Merkel U; Sigusch H; Hoffmann A
    Eur J Clin Pharmacol; 1994; 46(2):175-7. PubMed ID: 8039540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interindividual variability of coumarin 7-hydroxylation in healthy volunteers.
    Rautio A; Kraul H; Kojo A; Salmela E; Pelkonen O
    Pharmacogenetics; 1992 Oct; 2(5):227-33. PubMed ID: 1306122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Grapefruit component interacting with rat and human P450 CYP3A: possible involvement of non-flavonoid components in drug interaction.
    Fukuda K; Ohta T; Yamazoe Y
    Biol Pharm Bull; 1997 May; 20(5):560-4. PubMed ID: 9178939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of grapefruit juice and smoking on verapamil concentrations in steady state.
    Fuhr U; Müller-Peltzer H; Kern R; Lopez-Rojas P; Jünemann M; Harder S; Staib AH
    Eur J Clin Pharmacol; 2002 Apr; 58(1):45-53. PubMed ID: 11956673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug interactions with grapefruit juice. Extent, probable mechanism and clinical relevance.
    Fuhr U
    Drug Saf; 1998 Apr; 18(4):251-72. PubMed ID: 9565737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Grapefruit-felodipine interaction: effect of unprocessed fruit and probable active ingredients.
    Bailey DG; Dresser GK; Kreeft JH; Munoz C; Freeman DJ; Bend JR
    Clin Pharmacol Ther; 2000 Nov; 68(5):468-77. PubMed ID: 11103749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Grapefruit juice-felodipine interaction: effect of naringin and 6',7'-dihydroxybergamottin in humans.
    Bailey DG; Kreeft JH; Munoz C; Freeman DJ; Bend JR
    Clin Pharmacol Ther; 1998 Sep; 64(3):248-56. PubMed ID: 9757148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of coumarin metabolism in Turkish population.
    Cok I; Aygün Kocabaş N; Cholerton S; Karakaya AE; Sardaş S
    Hum Exp Toxicol; 2001 Apr; 20(4):179-84. PubMed ID: 11393269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Grapefruit juice increases oral nimodipine bioavailability.
    Fuhr U; Maier-Brüggemann A; Blume H; Mück W; Unger S; Kuhlmann J; Huschka C; Zaigler M; Rietbrock S; Staib AH
    Int J Clin Pharmacol Ther; 1998 Mar; 36(3):126-32. PubMed ID: 9562227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.